CMEA Capital

company

About

CMEA Capital caters seed, early, and later stage venture, private equity, and debt financing investments and is based in California.

  • 11 - 50

Details

Industries
Banking,Finance,Venture Capital
Founded date
Jan 1, 1989
Number Of Employee
11 - 50
Operating Status
Close
Investor Type
Venture Capital

CMEA closed in April of 2015 and has unveiled its new corporate identity as [Presidio Partners](https://www.crunchbase.com/organization/presidio-partners). CMEA Capital is a venture capital firm with a clear focus on life sciences, high technology, and energy and materials investments. We believe that the most successful venture backed companies are those that are science based, with experienced teams that have a vision. As a result, CMEA typically invests in companies that have cutting edge and highly differentiated technology at their core and founding teams of the highest caliber still in place. These are companies that have the potential to transform their industries.

CMEA Capital was founded in 1989 and maintains offices in San Francisco and Menlo Park. We invest in both early and late stage science-focused ventures, and leverage a strong network of corporate, investment, and entrepreneurial relationships on behalf of portfolio companies. Our partners and associates have extensive science, engineering, and operational backgrounds, providing us the confidence to look beyond today's technology. We apply our focus on science and teams to our collaborations with entrepreneurs and venture investment partners who are changing the world, one great company at a time.

Investments

Number of Investments
Number of Lead Investments
3
1
CMEA Capital has made 3 investments. Their most recent investment was on Aug 31, 2011, when Ardelyx raised $30M.
Date Company Name
Round Money Raised Industry Lead Investor
Aug 31, 2011 Ardelyx
Series B $30M Biotechnology
Jun 12, 2008 Ardelyx
Series A $26.09M Biotechnology Yes
Aug 14, 2006 Codexis
Series D $37M Biotechnology